IL100179A0 - The use of carbazones as novel active ingredients in medicaments - Google Patents

The use of carbazones as novel active ingredients in medicaments

Info

Publication number
IL100179A0
IL100179A0 IL100179A IL10017991A IL100179A0 IL 100179 A0 IL100179 A0 IL 100179A0 IL 100179 A IL100179 A IL 100179A IL 10017991 A IL10017991 A IL 10017991A IL 100179 A0 IL100179 A0 IL 100179A0
Authority
IL
Israel
Prior art keywords
carbazones
medicaments
active ingredients
novel active
novel
Prior art date
Application number
IL100179A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL100179A0 publication Critical patent/IL100179A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL100179A 1990-12-06 1991-11-28 The use of carbazones as novel active ingredients in medicaments IL100179A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH386890 1990-12-06
CH84491 1991-03-20
CH98691 1991-04-03

Publications (1)

Publication Number Publication Date
IL100179A0 true IL100179A0 (en) 1992-08-18

Family

ID=27172464

Family Applications (1)

Application Number Title Priority Date Filing Date
IL100179A IL100179A0 (en) 1990-12-06 1991-11-28 The use of carbazones as novel active ingredients in medicaments

Country Status (8)

Country Link
US (1) US5177091A (ja)
EP (1) EP0494047A1 (ja)
JP (1) JPH04290824A (ja)
KR (1) KR920011487A (ja)
AU (1) AU8838291A (ja)
CA (1) CA2056894A1 (ja)
IE (1) IE914234A1 (ja)
IL (1) IL100179A0 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753147A1 (en) * 1994-03-30 1997-01-15 Novartis AG Screening method using the rzr receptor family
IS4518A (is) * 1997-07-09 1999-01-10 Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group Nýtt lyfjaform fyrir bóluefni
US6855332B2 (en) * 2002-07-03 2005-02-15 Lyfjathroun Hf. Absorption promoting agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699116A (en) * 1965-10-29 1972-10-17 Ciba Geigy Corp 2,2'-azines of 2,4-thiazolidinediones
GB1325061A (en) * 1970-07-03 1973-08-01 Ciba Geigy Ag Process for the production of azines
AR204619A1 (es) * 1973-02-13 1976-02-20 Ciba Geigy Ag Procedimiento para la elaboracion de un nuevo derivado de 2,2-azina-2,4-tiazolidindiona
ATE4387T1 (de) * 1979-07-04 1983-08-15 Farmitalia Carlo Erba S.P.A. Anthracyclin-glycoside, verfahren zu ihrer herstellung und sie enthaltende therapeutische zusammensetzung.
DE3269209D1 (en) * 1982-01-22 1986-03-27 Ciba Geigy Ag Substituted thiazolidinylic esters of mineral acids
US4582841A (en) * 1983-07-19 1986-04-15 Ciba-Geigy Corporation Substituted thiazolidinyl esters of mineral acids

Also Published As

Publication number Publication date
EP0494047A1 (de) 1992-07-08
AU8838291A (en) 1992-06-11
KR920011487A (ko) 1992-07-24
CA2056894A1 (en) 1992-06-07
IE914234A1 (en) 1992-06-17
US5177091A (en) 1993-01-05
JPH04290824A (ja) 1992-10-15

Similar Documents

Publication Publication Date Title
PH25126A (en) 1,5-diaryl-3-substituted pyrazoles pharmaceutical compositions and use
HK94994A (en) Skin care compositions
EP0542914A4 (en) Improved diagnostic and therapeutic compositions
HUT52078A (en) Herebicidal compositions comprising thiazole derivatives as active ingredient and process for producing the active ingredients
IL89180A0 (en) Synergistic arthropodical compositions comprising pyrethroidal active ingredients
EP0334679A3 (en) Improvements in or relating to the inactivation of infectious agents
GB2205092B (en) Doping compositions and their use
HUT39957A (en) Insecticide and acaricide compositions and process for preparing the active ingredients
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
AR242084A1 (es) Una composicion bactericida.
HUT46929A (en) Sposob poluchenija aminoglycoside-steroides and pharmaceutical compositions containing them as active components
IL98934A0 (en) Stable pharmaceutical compositions and their preparation
EP0437026A3 (en) Use of tandospirone in the treatment of depression
IL89816A0 (en) Synergistically active veterinary compositions and their preparation
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
GB2228274B (en) Surface active compositions their production and use
IL100179A0 (en) The use of carbazones as novel active ingredients in medicaments
IL82726A (en) Pharmaceutical compositions comprising anticonvulsively active 1-phenalkylimidazole-4-and/or-5-carboxamides and certain novel phenalkylimidazoles and their manufacture
ZA919604B (en) The use of carbozones as novel active ingredients in medicaments
HU896610D0 (en) Herbicid composition comprising substituted-sulfonyl-urea as active ingredient and process for preparation thereof
ZA909684B (en) Sterilizing compositions and their use
GB2238721B (en) Sterilizing compositions and their use
EG18336A (en) Insectidal composition comprising more than one active ingredients
EP0417632A3 (en) 2-ethoxymethyl-5-hydroxy-gamma-pyrone and melanogenesis-inhibiting endermic preparation containing the same compound as active ingredient
GB9027449D0 (en) Skin care composition